Mesoblast Limited (MESO)

Mesoblast Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Cash & Equivalents	77.55	71.32	60.45	136.88	129.33	50.43
Cash & Cash Equivalents	77.55	71.32	60.45	136.88	129.33	50.43
Cash Growth	-9.30%	17.98%	-55.84%	5.84%	156.47%	33.53%
Receivables	4	7	4.4	4.84	1.57	4.06
Other Current Assets	3.6	3.34	4.99	6.5	5.65	8.04
Total Current Assets	85.15	81.66	69.84	148.23	136.55	62.52
Property, Plant & Equipment	5.5	6.49	9.97	12.14	10.27	0.83
Long-Term Investments	0.83	1.76	1.76	2.08	1.87	2.32
Goodwill and Intangibles	576.56	577.18	578.65	580.55	581.6	583.13
Other Long-Term Assets	2.24	2.33	1.93	1.72	3.31	3.32
Total Long-Term Assets	585.13	587.76	592.31	596.49	597.05	589.59
Total Assets	670.29	669.42	662.14	744.72	733.6	652.12
Accounts Payable	10.76	20.15	23.08	19.6	24.97	13.06
Current Debt	11.39	10.01	8.2	55.97	35.97	14.01
Other Current Liabilities	9.22	11.83	20.09	18.71	29.2	17.26
Total Current Liabilities	31.37	41.98	51.37	94.27	90.14	44.33
Long-Term Debt	110.61	106.48	98.7	49.53	63.34	67.28
Other Long-Term Liabilities	19.57	19.11	15.02	19.52	30.79	59.45
Total Long-Term Liabilities	130.19	125.6	113.73	69.05	94.13	126.73
Total Liabilities	161.55	167.58	165.1	163.32	184.28	171.06
Total Debt	122	116.5	106.91	105.5	99.31	81.29
Debt Growth	11.28%	8.97%	1.34%	6.22%	22.18%	36.85%
Retained Earnings	-853.34	-820.81	-738.92	-647.57	-548.76	-469.99
Shareholders' Equity	508.73	501.84	497.04	581.4	549.33	481.05
Net Cash / Debt	-44.45	-45.18	-46.46	31.39	30.01	-30.86
Net Cash / Debt Growth	-	-	-	4.57%	-	-
Working Capital	53.79	39.68	18.46	53.95	46.41	18.19
Book Value Per Share	6.25	6.81	7.65	8.98	10.22	9.65

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).